CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 138 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $673 | +216.0% | 57,626 | +262.9% | 0.01% | +250.0% |
| Q2 2023 | $213 | -94.2% | 15,879 | -92.9% | 0.00% | -95.6% |
| Q1 2023 | $3,683 | +480.9% | 222,178 | +551.5% | 0.04% | +400.0% |
| Q4 2022 | $634 | -99.9% | 34,105 | +2.7% | 0.01% | +80.0% |
| Q3 2022 | $426,000 | -67.7% | 33,217 | -82.3% | 0.01% | -64.3% |
| Q2 2022 | $1,318,000 | +47.1% | 188,119 | +42.1% | 0.01% | +180.0% |
| Q4 2021 | $896,000 | +409.1% | 132,366 | +296.5% | 0.01% | +400.0% |
| Q3 2021 | $176,000 | -51.5% | 33,380 | -69.3% | 0.00% | -85.7% |
| Q4 2020 | $363,000 | +57.8% | 108,714 | +117.9% | 0.01% | 0.0% |
| Q2 2020 | $230,000 | – | 49,888 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 213,609 | $1,446,000 | 2.75% |
| GABLES CAPITAL MANAGEMENT INC. | 449,164 | $3,041,000 | 1.81% |
| Prairiewood Capital, LLC | 261,403 | $1,770,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 9,572,000 | $64,802,000 | 1.06% |
| Quantedge Capital Pte Ltd | 360,100 | $2,438,000 | 1.03% |
| SummerHaven Investment Management, LLC | 151,384 | $1,025,000 | 0.55% |
| GLOBEFLEX CAPITAL L P | 609,030 | $4,124,000 | 0.42% |
| EAM Global Investors LLC | 347,899 | $2,355,000 | 0.42% |
| Lanham O'Dell & Company, Inc. | 50,000 | $339,000 | 0.27% |
| EAM Investors, LLC | 239,071 | $1,619,000 | 0.27% |